Somatropin
Approved medicineGet notified when the evidence changes.
The FDA has approved a version of this as a medicine, so it has been through large studies in people.
Compiled and reviewed by the PeptideSearch Editorial Team · Status checked 2026-08-04
Also called rhGH / Human growth hormone / Genotropin / Norditropin / Humatrope
Lab-made human growth hormone. Approved for specific medical conditions and prescription-only.
Official status: Pharmacies may compound it · Checked 2026-08-04
Can a doctor prescribe this?
- Small pharmacy (503A)
- Never put forward to FDA
- Large outsourcing facility (503B)
- Never put forward to FDA
An approved prescription drug. US federal law separately restricts distributing it for uses it was not approved for.
Why both lines above can be true: this compound is the active ingredient of a drug the FDA has already approved, and a pharmacy may compound with a bulk substance that is “a component of a drug approved by the Secretary” — a separate route in the law from the list of substances put forward for review. So it never had to be nominated for that list. The wording is in section 503A(b)(1)(A)(i)(II) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353a). The substance must also be made by an FDA-registered establishment and come with a certificate of analysis for each lot.
503A is a pharmacy making a single prescription for one patient. 503B is a facility making batches. They are governed by separate lists. Where a category is shown, it is a position on the FDA's list of substances that have been put forward and are still being worked through — not the final list, which is set by rulemaking. Category 1 means the FDA does not plan to act against a pharmacy that makes it while the review runs.
Doses used in research
Taken word for word from the studies and trials listed on this page. This is not a recommendation and not a dose for anyone to take.
This is a sample, not the whole literature.
About 35,000 papers mentioning this compound have been published. We show a selected sample of 137 of them, not the full literature. How we choose them · count checked 2026-08-23
- Study in peopleChildren with Growth Hormone Deficiency Treated with Lonapegsomatropin Demonstrated Sustained Height Improvements for up to 6 Years: enliGHten Trial Final Results.
Hormone research in paediatrics · 2026
- Study in peopleEfficacy and safety of once-weekly somatrogon following up to 4 years of treatment in Japanese children with growth hormone deficiency: results from an open-label extension of a phase 3 study.
Endocrine journal · 2026
- Study in peopleOnce-Weekly Lonapegsomatropin Was Efficacious and Well Tolerated in Chinese Children with Growth Hormone Deficiency: Results from a Phase 3 Randomized Trial.
Hormone research in paediatrics · 2026
- Study in peopleEstrogen deficiency and risk of hearing loss in pediatric Turner syndrome.
The Journal of clinical investigation · 2026
- Study in peopleEfficacy and Safety of Once-Weekly Lonapegsomatropin in Adults With Growth Hormone Deficiency: foresiGHt Trial Results.
The Journal of clinical endocrinology and metabolism · 2026
- Study in peopleNavepegritide combined with lonapegsomatropin for the treatment of children with achondroplasia: 52-week results from the phase 2 COACH trial.
European journal of endocrinology · 2026
- Study in peopleComparative effects of local denosumab and recombinant human growth hormone on periodontal remodeling in experimental periodontitis.
Journal of stomatology, oral and maxillofacial surgery · 2026
- Study in peopleAcute effects of two different combined exercise modalities on executive function and circulating neurotrophic factors in young healthy adults.
European journal of applied physiology · 2026
- Study in peopleRecombinant human growth hormone (rHGH) for muscle enhancement in knee osteoarthritis: protocol for a pilot, randomised placebo-controlled trial.
BMJ open · 2026
- Study in peopleEfficacy and safety of once-weekly PEG-rhGH versus daily GH in children with Noonan syndrome: a 52-week, randomized controlled trial
2026
- Study in peopleThe efficacy and safety of rhGH treatment combined with letrozole/GnRHa in adolescent boys.
BMC pediatrics · 2025
- Study in peopleEfficacy, safety, and insulin-like growth factor I of weekly somapacitan in children with growth hormone deficiency: 3-year results from REAL4.
European journal of endocrinology · 2025
- Study in peopleStudy of Testosterone and Recombinant Human Growth Hormone in Facioscapulohumeral Muscular Dystrophy.
Neurology. Genetics · 2025
- Study in peoplePhase 1 study and population PK/PD modeling of long-acting growth hormone, GB08, to guide pediatric dosing.
European journal of endocrinology · 2025
- Study in peopleA Novel Y-Shaped Pegylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency.
The Journal of clinical endocrinology and metabolism · 2025
- Study in peopleImpact of non-weight-dependent low-dose somatropin on bone accrual in childhood-onset GH deficient in the transition: an 18-month randomized controlled trial.
Jornal de pediatria · 2025
- Study in peopleEfficacy in Japanese adults with growth hormone deficiency receiving weekly somapacitan or daily growth hormone: results from phase 3 REAL 1 trial.
Frontiers in endocrinology · 2025
- Study in peopleImprovement in body composition of Japanese participants with Prader-Willi syndrome following somatropin treatment: an open-label, multi cohort Phase 3 study.
Endocrine journal · 2025
- Study in peopleSafety and effectiveness of a biosimilar somatropin (Cinnatropin®) in children and adolescents receiving growth hormone therapy over 1 year: a registry-based phase IV study.
European journal of pediatrics · 2025
- Study in peopleA Phase 2 Study of PEGylated Recombinant Human Growth Hormone for 52 Weeks in Short Children Born Small for Gestational Age in China.
Clinical endocrinology · 2025
- Study in peopleEvaluation of the safety and efficacy of biosimilar recombinant growth hormone in children with growth hormone deficiency: non-inferiority, randomized, parallel, multicentric and Phase III trial.
Expert opinion on drug safety · 2025
- Study in peoplePopulation pharmacokinetics/pharmacodynamics and safety of YPEG-rhGH in elderly subjects.
Frontiers in pharmacology · 2025
- Study in peopleA Randomized, Cross-Over Study Investigating the Comparability of Somatrogon-ghla in 2 Different Drug Product Presentations.
Clinical pharmacology in drug development · 2024
- Study in people<i>Post hoc</i> subgroup analysis of Asian children with paediatric GHD from the global phase 3 efficacy and safety study of once-weekly somatrogon vs. once-daily somatropin.
Journal of pediatric endocrinology & metabolism : JPEM · 2024
- Study in peopleGrowth hormone treatment in pre-pubertal short Chinese children with chronic kidney disease prior to transplantation.
Pediatric research · 2023
- Study in peopleEarly recombinant human growth hormone treatment improves mental development and alleviates deterioration of motor function in infants and young children with Prader-Willi syndrome.
World journal of pediatrics : WJP · 2023
- Study in peopleAn open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment.
Journal of pediatric endocrinology & metabolism : JPEM · 2023
- Study in peopleSwitching to Weekly Lonapegsomatropin from Daily Somatropin in Children with Growth Hormone Deficiency: The fliGHt Trial.
Hormone research in paediatrics · 2022
- Study in peopleSafety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results.
The Journal of clinical endocrinology and metabolism · 2022
- Study in peopleA Randomized Controlled Phase 3 Study on the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Idiopathic Short Stature.
Frontiers in endocrinology · 2022
- Study in peopleEvaluation of efficacy and safety of long-acting PEGylated recombinant human growth hormone (Jintrolong) for patients with growth hormone deficiency.
Journal of pediatric endocrinology & metabolism : JPEM · 2022
- Study in peopleEfficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study.
The Journal of clinical endocrinology and metabolism · 2022
- Study in peopleEfficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study.
Hormone research in paediatrics · 2022
- Study in peopleLong-acting PEGylated growth hormone in children with idiopathic short stature.
European journal of endocrinology · 2022
- Study in peopleA proof-of-concept study of growth hormone in children with Phelan-McDermid syndrome.
Molecular autism · 2022
- Study in peopleThe pharmacokinetic and pharmacodynamic properties and short-term outcome of a novel once-weekly PEGylated recombinant human growth hormone for children with growth hormone deficiency.
Frontiers in endocrinology · 2022
- Study in peopleEffect of recombinant human growth hormone on liver fat content in young adults with nonalcoholic fatty liver disease.
Clinical endocrinology · 2021
- Study in peopleReduced Effectiveness and Comparable Safety in Biweekly <i>vs.</i> Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial.
Frontiers in endocrinology · 2021
- Study in peopleSafety and Effectiveness of Recombinant Human Growth Hormone in Children with Turner Syndrome: Data from the PATRO Children Study.
Hormone research in paediatrics · 2021
- Study in peopleEfficacy and safety of the recombinant human growth hormone in short children born small for gestational age: A randomized, multicentre, comparative phase III trial.
Medicine · 2021
- Study in peopleRecombinant growth hormone therapy in children with Turner Syndrome in Korea: a phase III Randomized Trial.
BMC endocrine disorders · 2021
- Study in peopleWeekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial.
The Journal of clinical endocrinology and metabolism · 2021
- Study in peopleLong-term efficacy and safety of two doses of Norditropin<sup>®</sup> (somatropin) in Noonan syndrome: a 4-year randomized, double-blind, multicenter trial in Japanese patients.
Endocrine journal · 2020
- Study in peopleEffects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial.
Orphanet journal of rare diseases · 2019
- Study in peopleThe effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients.
The Journal of clinical endocrinology and metabolism · 1999
- Study in peopleRandomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.
Lancet (London, England) · 1998
- Study in peopleEffects of short term administration of recombinant human growth hormone to elderly people.
The Journal of clinical endocrinology and metabolism · 1990
- Study in peopleEffects of recombinant human growth hormone on donor-site healing in severely burned children.
Annals of surgery · 1990
- Study in peopleThe effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.
The New England journal of medicine · 1989
- Data from people, not a trialTwo-year real-world experience with somatrogon in children and adolescents with growth hormone deficiency.
Frontiers in endocrinology · 2026
- Data from people, not a trialLong-Term Metabolic Effects of Recombinant Human Growth Hormone Therapy in Childhood- Onset Craniopharyngioma Survivors
2026
- Data from people, not a trialAccumulated safety data of recombinant human growth hormone therapy in Korean children over a 10-year period: interim results from the LG Growth Study.
Endocrine connections · 2026
- Data from people, not a trialEpileptic seizures temporally associated with recombinant human growth hormone therapy in children: A case series of three patients.
SAGE open medical case reports · 2026
- Data from people, not a trialPhenotypic Characterization and recombinant human growth hormone Therapeutic Response in ACAN Children With Short Stature: A Real-World Study.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2026
- Data from people, not a trialReal-World Adult Height Outcomes in Girls with Central Precocious Puberty Receiving GnRHa Monotherapy or Combined with Growth Hormone: A Cohort Study in China.
Advances in therapy · 2026
- Data from people, not a trialIs Somatrogon different? 6-month clinical outcomes and follow-up data in Turkish children transitioned from Somatropin to Somatrogon.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2026
- Data from people, not a trialCost-Effectiveness of Combined GnRHa and rhGH Therapy versus Monotherapy in Girls with Central Precocious Puberty Based on a Markov Model Integrating Real-World and Pooled Published Cohort Data
2026
- Data from people, not a trialImpact of growth hormone treatment on childhood growth patterns in Kermanshah: A retrospective cohort study.
Journal of education and health promotion · 2026
- Data from people, not a trialLongitudinal changes in nonfunctioning pituitary neuroendocrine tumors in children receiving growth hormone therapy: A comparison with untreated patients.
Archivos argentinos de pediatria · 2026
- Data from people, not a trialLinear growth in pediatric kidney transplant recipients.
Pediatric nephrology (Berlin, Germany) · 2026
- Data from people, not a trialAnalysis of the effect of recombinant human growth hormone therapy on metabolic parameters in patients with severe growth hormone deficiency in adulthood.
Endokrynologia Polska · 2026
- Data from people, not a trialAnalysis of differences in response to long-acting growth hormone therapy and influencing factors between patients with idiopathic short stature (ISS) and growth hormone deficiency (GHD).
Translational pediatrics · 2026
- Data from people, not a trialPituitary magnetic resonance imaging abnormalities and 1-year growth response in children with idiopathic growth hormone deficiency.
Annals of pediatric endocrinology & metabolism · 2026
- Data from people, not a trialCase Report: Growth hormone deficiency and response to treatment in MIRAGE syndrome: expanding the endocrine phenotype.
Frontiers in endocrinology · 2026
- Data from people, not a trialCase Report: Sequential treatment of growth hormone deficiency and central precocious puberty in a girl with <i>EP300</i>-mutated Rubinstein-Taybi syndrome.
Frontiers in pediatrics · 2026
- Data from people, not a trialEffects of Growth Hormone Therapy on Sleep-Disordered Breathing and Metabolic Parameters in Patients with Prader–Willi Syndrome According to Genetic Subtype
2026
- Data from people, not a trialWeekly pegylated recombinant human growth hormone for prepubertal children with growth hormone deficiency: adherence advantage drives superior short-term efficacy over daily rhGH.
Translational pediatrics · 2026
- Data from people, not a trialTherapeutic efficacy of leuprorelin acetate combined with rhGH in girls with ICPP and Its impact on body height and secondary sexual characteristics.
Pakistan journal of medical sciences · 2026
- Data from people, not a trialThe relationship between pituitary size and the response to recombinant human growth hormone therapy in children with isolated growth hormone deficiency.
Frontiers in endocrinology · 2026
- Data from people, not a trialFirst reported case of Turner syndrome with Krabbe disease in a child: a case report.
Translational pediatrics · 2026
- Data from people, not a trialRevisiting HIV-Associated Wasting: Results from a U.S. Cross-Sectional Survey of Health Care Providers' Knowledge, Attitude, and Current Practices.
AIDS research and human retroviruses · 2026
- Data from people, not a trialMetabolic and muscular effects of switching from somatropin to somapacitan in adults with growth hormone deficiency.
The Journal of clinical endocrinology and metabolism · 2026
- Data from people, not a trialInterpretable Machine Learning for Predicting Suboptimal 12-Month Growth Response to Recombinant Human Growth Hormone in Children with Idiopathic Short Stature: A Dual-Center External Validation Study.
Diagnostics (Basel, Switzerland) · 2026
- Data from people, not a trialEffectiveness of Recombinant Human Growth Hormone Therapy in Small-for-Gestational-Age Children With Short Stature: A Stratified Analysis Based on Genetic Variant Status.
Clinical endocrinology · 2026
- Data from people, not a trialWeekly somatrogon vs daily somatropin: a propensity score-matched analysis of growth outcomes from clinical data vs KIGS.
Journal of the Endocrine Society · 2026
- Data from people, not a trialCost-effectiveness of a connected injection device for daily somatropin therapy in pediatric growth hormone deficiency in Spain: a scenario-based microsimulation analysis using real-world data.
Journal of comparative effectiveness research · 2026
- Data from people, not a trialAssociation between recombinant human growth hormone therapy and refractive status in Korean children with idiopathic short stature: a cross-sectional study.
Scientific reports · 2026
- Data from people, not a trialRecombinant human growth hormone in pediatric patients using the FAERS database: Safety profile and update for the period 2004 - 2024.
International journal of clinical pharmacology and therapeutics · 2026
- Data from people, not a trialEfficacy and influencing factors of recombinant human growth hormone therapy in children with Turner syndrome: a single-center retrospective cohort study.
Translational pediatrics · 2026
- Data from people, not a trialGrowth Hormone Therapy in Children Born Small for Gestational Age with Persistent Short Stature: Lessons Learned from Real-World International Databases and Directions for Future Research.
Hormone research in paediatrics · 2026
- Data from people, not a trialPhysician experience with once-weekly somatrogon versus once-daily rhGH regimen in pediatric patients with growth hormone deficiency: a cross-sectional survey of physicians from the global phase 3 study.
Frontiers in endocrinology · 2023
- Data from people, not a trialEffect of arginine on serum-levels of human growth-hormone.
Lancet (London, England) · 1965
- Animal study, rats or miceDesign, Synthesis, and Proof-of-Concept Bioassay of an Encapsulated mRNA for Human Growth Hormone.
Current issues in molecular biology · 2026
- Testing of products for sale, not a health studyDevelopment and validation of a mechanism-based Ba/F3-hGHR bioassay for the potency assessment of recombinant human growth hormone.
Analytical biochemistry · 2026
- Hypothesis, not a tested studyNew directions in growth hormone treatment in children.
Pediatric endocrinology, diabetes, and metabolism · 2025
- Chemistry or materials paper, not a health studyHuman growth hormone and extracellular domain of its receptor: crystal structure of the complex.
Science (New York, N.Y.) · 1992
- Drug information page, not a studySomatropin
2006
- Precision Dosing for Pediatric Growth Hormone Deficiency With Daily and Weekly Growth Hormone.
MedComm · 2026
- Once-Weekly Somatrogon in Pediatric Growth Hormone Deficiency: Real-World Efficacy, Safety, and Quality-of-Life Findings
Journal of clinical research in pediatric endocrinology · 2026
- Clinical evidence, practical contradictions, and monitoring of rhGH-assisted height enhancement in children with CAH.
Journal of pediatric endocrinology & metabolism : JPEM · 2026
- [Multiple clinical effects of recombinant human growth hormone therapy].
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
- Metabolic and bone effects of long-acting polyethylene glycol-recombinant human growth hormone in growth hormone deficiency during the transition period: a prospective study.
Annals of pediatric endocrinology & metabolism · 2026
- Growth outcomes following recombinant human growth hormone therapy in Zhu-Tokita-Takenouchi-Kim syndrome.
JCEM case reports · 2026
- Coexistence of Incontinentia Pigmenti and Pituitary Aplasia in a Female Child.
Cureus · 2026
- A 10-Year Follow-up of Schmid Metaphyseal Chondrodysplasia with Partial Growth Hormone Deficiency
2026
- Familial short stature: genetic architecture, risk stratification, and precision management.
Frontiers in endocrinology · 2026
- PEG-rhGH successfully improved the height of a patient with rare 45,X[40]/46,XY[31] disorder of sex development: the first reported case.
Translational pediatrics · 2026
- Pharmacogenetic hypersensitivity to somatropin in a child with severe growth hormone deficiency and <i>MC4R</i> p.V166I variant.
Journal of pediatric endocrinology & metabolism : JPEM · 2026
- Treatment Outcomes in 84 Male Children with Accelerated Pubertal Progression: A Comparative Analysis ofGnRHa, Combined GH Therapy and Aromatase Inhibitor
2026
- Low Bone Mass is Common and Associated with Delayed Estrogen Replacement Therapy in Adult Brazilian Women with Turner Syndrome.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry · 2026
- Molecular Dynamics Simulation and Characterization of GelMA/HA Composite Microneedles for Potential Growth Hormone Transdermal Delivery.
Gels (Basel, Switzerland) · 2026
- PRKAR1A-related acrodysostosis with partial growth hormone deficiency: 18-month response to recombinant human growth hormone.
Hormones (Athens, Greece) · 2026
- Comparing the efficacy and safety of weekly somatrogon with daily somatropin in Asian children living with growth hormone deficiency: a plain language summary of publication.
Therapeutic advances in endocrinology and metabolism · 2025
- Global trends in recombinant human growth hormone for the treatment of idiopathic short stature: a bibliometric analysis.
Frontiers in medicine · 2025
- Safety and Effectiveness of a Biosimilar Recombinant Growth Hormone in Adults with Growth Hormone Deficiency: Analysis of Final Data from PATRO Adults, an International Post-Marketing Surveillance Study.
Drug design, development and therapy · 2024
- Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency.
European journal of endocrinology · 2022
- Efficacy of Growth Hormone Treatment in Children With Chronic Kidney Disease: Tunisian Experience.
Indian pediatrics · 2021
- Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
Journal of pediatric endocrinology & metabolism : JPEM · 2021
- A preliminary study of growth hormone in the treatment of dilated cardiomyopathy.
The New England journal of medicine · 1996
- Human growth hormone prevents the protein catabolic side effects of prednisone in humans.
The Journal of clinical investigation · 1990
- Adrenergic receptor control mechanism for growth hormone secretion.
The Journal of clinical investigation · 1968
- Use of helical wheels to represent the structures of proteins and to identify segments with helical potential.
Biophysical journal · 1967
- No abstract available, not yet classifiedAcute metabolic response to human growth hormone in different types of dwarfism.
British medical journal · 1967
- No abstract available, not yet classifiedThe problem of short stature in childhood: growth hormone deficiency and its treatment with human growth hormone.
Medical times · 1966
- No abstract available, not yet classifiedEffects of estrogen and sex difference on secretion of human growth hormone.
The Journal of clinical endocrinology and metabolism · 1965
- No abstract available, not yet classifiedA radio-immunoelectrophoretic assay for human growth hormone.
The Biochemical journal · 1964
- No abstract available, not yet classifiedHUMAN GROWTH HORMONE. CLINICAL MEASUREMENT, RESPONSE TO HYPOGLYCEMIA AND SUPPRESSION BY CORTICOSTEROIDS.
The New England journal of medicine · 1964
- No abstract available, not yet classifiedA SENSITIVE DOUBLE ANTIBODY IMMUNOASSAY FOR HUMAN GROWTH HORMONE IN PLASMA.
Nature · 1964
- No abstract available, not yet classifiedIMMUNOASSAY OF HUMAN GROWTH HORMONE IN PLASMA.
Nature · 1963
- No abstract available, not yet classifiedSecretion of human growth hormone: physiologic and experimental modification.
Metabolism: clinical and experimental · 1963
- Hypoglycemia: a potent stimulus to secretion of growth hormone.
Science (New York, N.Y.) · 1963
- No abstract available, not yet classifiedTHE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.
The Biochemical journal · 1963
- No abstract available, not yet classifiedPreparation of iodine-131 labelled human growth hormone of high specific activity.
Nature · 1962
- No abstract available, not yet classifiedSome effects of human growth hormone on renal hemodynamics and on tubular phosphate transport in man.
The Journal of clinical investigation · 1962
- No abstract available, not yet classifiedEffects of human growth hormone in man.
The Journal of clinical investigation · 1960
- No abstract available, not yet classifiedTreatment of a pituitary dwarf with human growth hormone.
The Journal of clinical endocrinology and metabolism · 1958
- Review of earlier workCan long-acting growth hormone improve adherence in pediatric growth hormone deficiency?
Endocrine · 2026
- Review of earlier workComparison of efficacy and safety between long-acting growth hormone and short-acting growth hormone in isolated growth hormone deficiency: a systematic review and meta-analysis of 16 randomized controlled trials involving 2,435 pediatric patients.
Frontiers in pediatrics · 2026
- Review of earlier workOnce-weekly somapacitan vs. daily norditropin in GHD: a systematic review and meta-analysis of efficacy and safety in children and adults.
Endocrine · 2026
- Review of earlier workPatient and Caregiver Preferences for Once-Weekly Injection Devices for the Treatment of Growth Hormone Deficiency.
Journal of the Endocrine Society · 2026
- Review of earlier work[Prospects and mechanistic insights into the use of recombinant human growth hormone in the treatment of pediatric inflammatory bowel disease].
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
- Review of earlier workPredictors of Response to Growth Hormone Therapy in Children with Idiopathic Growth Hormone Deficiency: A Narrative Review.
Children (Basel, Switzerland) · 2026
- Review of earlier workCase Report: Clinical phenotypes and recombinant human growth hormone therapeutic exploration for a patient with Takenouchi-Kosaki syndrome harboring the <i>CDC42</i> p.Arg68Gln variant.
Frontiers in pediatrics · 2026
- Review of earlier workLong-Acting Growth Hormone Versus Daily Growth Hormone for Growth Hormone Deficiency Patients: A Network Meta-Analysis of Clinical Trials.
Endocrinology, diabetes & metabolism · 2026
- Review of earlier workGH-IGF-1 axis and rhGH outcomes in children with GHD, ISS and SGA: a systematic review and meta-analysis.
Journal of pediatric endocrinology & metabolism : JPEM · 2026
- Review of earlier workLong-Acting Growth Hormone for Pediatric Growth Hormone Deficiency.
Journal of the Endocrine Society · 2025
- Review of earlier workLong-acting PEGylated growth hormone in children with idiopathic short stature: time to reconsider our diagnostic and treatment policy?
European journal of endocrinology · 2023
Spot an error? corrections@peptidesearch.org